2020 Partners

Promega Logo

Expertise Partner

We share your passion for science. Promega is committed to excellence in developing a broad suite of technologies for oncology. Learn how NanoBRET Target Engagement technology is being used to: target histone deacetylases, bromodomains, kinases, E3 ligases, and GPCRs; perform quantitative determinations of test compound affinity; monitor ligand occupancy in live cells, in real-time; and adapted for use in broad-spectrum profiling to evaluate the live-cell selectivity for test compounds. Let’s collaborate.